- 专利标题: FARNESOID X RECEPTOR AGONISTS FOR THE TREATMENT OF DISEASE
-
申请号: US17836905申请日: 2022-06-09
-
公开(公告)号: US20220323414A1公开(公告)日: 2022-10-13
- 发明人: Kenneth SONG , Hubert CHEN , Brandee WAGNER
- 申请人: Metacrine, Inc.
- 申请人地址: US CA San Diego
- 专利权人: Metacrine, Inc.
- 当前专利权人: Metacrine, Inc.
- 当前专利权人地址: US CA San Diego
- 主分类号: A61K31/415
- IPC分类号: A61K31/415 ; A61P1/16 ; A61K9/00 ; A61K45/06
摘要:
Described herein are combination therapies with farnesoid X receptor (FXR) agonists, and methods of using such pharmaceutical compositions in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.